Skip to content

Hair Transplantation in Cicatricial Alopecia

EVALUATION OF THE EFFICACY OF FOLLICULAR UNIT EXTRACTION VERSUS FOLLICULAR UNIT EXTRACTION WITH PLATELETS RICH PLASMA IN TREATMENT OF CICATRICAL ALOPECIA

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04472715
Enrollment
20
Registered
2020-07-15
Start date
2020-01-05
Completion date
2020-12-05
Last updated
2021-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cicatricial Alopecia, Hair Transplantation

Keywords

hair loss, follicuular unit extraction, platelet rich plasma

Brief summary

follicular unit extraction as a method of hair transplantation in cicatricial alopecia

Detailed description

The study will include 20 patients with cicatrical alopecia.Patients will be randomly assigned into two groups:Group (A):include ten patients will undergo (FUE) alone. Group (B): include ten patients will undergo(FUE) and (PRP).3-Surgical technique: * Preoperative Investigations including complete blood count, coagulation profile and hepatitis viral markers. 1-Group(A): will undergo (FUE) * Washing the scalp with antiseptic shampoo before the procedure. * Tumuscentanaesthesia:The donor area is anesthetized with a lidocaine 1% solution diluted with 20 cc saline in addition to adrenaline. * Creation of micropunches(0.7-1 mm) using micromotor. * After removal of the punch,the follicular unit is extracted with Jweler's forceps. * Extracted grafts are then placed on chilled saline gauze for maximum four hours until ready for transplantation. * The recipient area is prepared with rectangular scalpel blades 1mm or hypodermic blades 0.9 mm. * Implantation using fine tipped jweler's forceps. * Finally, receptor and donor areas will be softly cleansed with saline and crepe bandage is applied. 2-Group (B): FUE+PRP * The same procedure will be done but grafts will be placed in Prp solution. * Prp session one week before transplantation then monthly for 3 monthes after (FUE). * Preparation of PRP * 10 cc blood will be aspirated in test tube contained a modified solution of anticoagulant,called acid-citrate-dextrose type (ACDA), in which the physiological pH will reached to preserve the platelet integrity. * The first spin of whole blood sample will be at 2500 rpm for 4 minutes * The second spin at 4000 for 20 minutes for obtained plasma. * Platelets are separated as a pellet at the bottom of the tube from platelet-poor plasma (PPP) above. The platelet-rich pellet is resuspended in remaining amount of plasma. The resulting suspension is used as PRP. * Prp is injected in the recipient area. 4-Follow up: * Follow up clinically by digital photographs and trichoscopy 1 week after operation, after 3 months and after 6 months.

Interventions

PROCEDUREfollicular unit extarcation and platelet rich plasma

hair transplantation procedure

Sponsors

Alexandria University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* • Patients with unacceptable visible scarring alopecia. * Adequate donor area. * patient free of signs of disease activity evidenced by trichoscopy. * Patients having inadequate laxity for a strip excision (too tight skin). * When previous scars of strip surgeries make further strips impossible.

Exclusion criteria

* • Inadequate donor area. * Signs of active disease or infection. * Patient who is not willing for long sessions for several hours or multiple sessions as needed due to the slowness of the process * Contraindications for surgical procedure as bleeding tendency. * Contraindications for PRP as (cardiovascular, autoimmune disorders, hematological disorders and neoplasms).

Design outcomes

Primary

MeasureTime frameDescription
hair regrowth6 monthstransplanted hair develop int new hair growth in bald area

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026